Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-12-05

Clinical Trial Update: Lidocaine and Triamcinolone vs Saline Trigger Point Injection for Treatment of Chronic Abdominal Wall Pain [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating lidocaine and triamcinolone versus saline trigger point injections for chronic abdominal wall pain has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lidocaine (Lidocaine)
  • Triamcinolone (triamcinolone)

Snippet

Sponsor: Temple University | Conditions: Chronic Abdominal Wall Pain, Abdominal Cutaneous Nerve Entrapment Syndrome | Phase 4 | Status: WITHDRAWN